73 related articles for article (PubMed ID: 31358409)
1. Immunogenicity of a recombinant fusion construct composed of intrinsically unstructured, low polymorphic segments derived from merozoite surface protein 2 and trophozoite exported protein 1.
Tiendrebeogo RW; Spallek R; Oehlmann W; Singh M; Theisen M; Nebie I; Moret R; Roussilhon C; Corradin G
Vaccine; 2019 Aug; 37(36):5332-5340. PubMed ID: 31358409
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
4. A newly characterized malaria antigen on erythrocyte and merozoite surfaces induces parasite inhibitory antibodies.
Michelow IC; Park S; Tsai SW; Rayta B; Pasaje CFA; Nelson S; Early AM; Frosch AP; Ayodo G; Raj DK; Nixon CE; Nixon CP; Pond-Tor S; Friedman JF; Fried M; Duffy PE; Le Roch KG; Niles JC; Kurtis JD
J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34342640
[TBL] [Abstract][Full Text] [Related]
5. Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity.
Tetteh KK; Osier FH; Salanti A; Kamuyu G; Drought L; Failly M; Martin C; Marsh K; Conway DJ
Infect Immun; 2013 Oct; 81(10):3835-42. PubMed ID: 23897617
[TBL] [Abstract][Full Text] [Related]
6. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
7. Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.
Krishnarjuna B; Andrew D; MacRaild CA; Morales RA; Beeson JG; Anders RF; Richards JS; Norton RS
Sci Rep; 2016 Feb; 6():20613. PubMed ID: 26865062
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
[No Abstract] [Full Text] [Related]
9. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin response to the low polymorphic Pf113 antigen in children from Lastoursville, South-East of Gabon.
Imboumy-Limoukou RK; Maghendi-Nzondo S; Kouna CL; Bounaadja L; Mbang S; Biteghe JC; Eboumbou C; Prugnolle F; Florent I; Lekana-Douki JB
Acta Trop; 2016 Nov; 163():149-56. PubMed ID: 27523305
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.
Balam S; Olugbile S; Servis C; Diakité M; D'Alessandro A; Frank G; Moret R; Nebie I; Tanner M; Felger I; Smith T; Kajava AV; Spertini F; Corradin G
Malar J; 2014 Dec; 13():510. PubMed ID: 25526742
[TBL] [Abstract][Full Text] [Related]
13. Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c.
Olugbile S; Kulangara C; Bang G; Bertholet S; Suzarte E; Villard V; Frank G; Audran R; Razaname A; Nebie I; Awobusuyi O; Spertini F; Kajava AV; Felger I; Druilhe P; Corradin G
Infect Immun; 2009 Dec; 77(12):5701-9. PubMed ID: 19786562
[TBL] [Abstract][Full Text] [Related]
14. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
[TBL] [Abstract][Full Text] [Related]
16. PfRON3 is an erythrocyte-binding protein and a potential blood-stage vaccine candidate antigen.
Zhao X; Chang Z; Tu Z; Yu S; Wei X; Zhou J; Lu H; Jiang N; Chen Q
Malar J; 2014 Dec; 13():490. PubMed ID: 25495792
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes.
Sakamoto H; Takeo S; Maier AG; Sattabongkot J; Cowman AF; Tsuboi T
Vaccine; 2012 Mar; 30(11):1972-80. PubMed ID: 22248820
[TBL] [Abstract][Full Text] [Related]
18. Immunization with merozoite surface protein 2 fused to a Plasmodium-specific carrier protein elicits strain-specific and strain-transcending, opsonizing antibody.
Eacret JS; Gonzales DM; Franks RG; Burns JM
Sci Rep; 2019 Jun; 9(1):9022. PubMed ID: 31227760
[TBL] [Abstract][Full Text] [Related]
19. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of dimorphic and C-terminal fragments of Plasmodium falciparum MSP2 formulated with different adjuvants in mice.
Balam S; Jafarshad A; Servis C; Frank G; Reed S; Pink R; Druilhe P; Spertini F; Corradin G
Vaccine; 2016 Mar; 34(13):1566-1574. PubMed ID: 26874325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
